genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
    • Cancer

      Poor Lung Cancer Response to Immunotherapy Linked to Commensal Bacteria, Suppressed…

      Animal Models

      How Well Do Mouse Models Mimic Human Disease?

      GPCRs

      IPO Raises $161M for GPCR-Based Drug Developer Structure Therapeutics

      Immunology

      How Signaling Molecules of the Immune System Protect against Disease

      Lung Cancer
      Cancer

      Changing Carcinogenic Cells in the Lungs with Novel Technology

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      Spatial Biology

      Spatial Biology Current State of the Art and What’s Coming Next

      Joseph M. Beechem
      Spatial Biology

      GEN Interview with Joseph M. Beechem, PhD, Chief Scientific Officer of…

      SMI Raw Data
      Spatial Biology

      Choosing the Right Spatial Technology

      CosMx SMI image
      Spatial Biology

      Spatial and NGS Dominate Proceedings at AGBT 2022

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      stocks go up
      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Home Bristol-Myers Squibb

Bristol-Myers Squibb

  • 10x Genomics
  • A-Lists
  • AgBio
  • Age-Related Disorders
  • Aging
  • AGTC
  • alcohol
  • Alexandria Real Estate Equities
  • Allergic Diseases
  • Application Notes
  • Artificial Intelligence
  • Autoimmune Disorders
  • Bacterial Diseases
  • Bacteriophage
  • Base Editing
  • Bayer
  • Biodefense/Bioterrorism
  • Bioethics
  • Biomarker Discovery
  • BioNTech
  • BioPerspectives
  • Blockchain
  • Blood Disorders
  • Boehringer Ingelheim
  • Bone disorders
  • Brexit
  • Bristol-Myers Squibb
  • Cardiovascular Disease
  • Careers
  • Celgene
  • Cell Analysis
  • Cell Biology
  • Cell Culture
  • Cell Line Development
  • Cell Signaling
  • Cell Therapy
  • Cellular Analysis
  • China
  • Chromatography
  • Circadian Rhythm
  • Commentary
  • Compound Synthesis
  • Computational Biology
  • Computer Simulation
  • COVID-19 Candidates
  • CRISPR
  • CRISPR/Cas9
  • Danaher
  • Developmental Disorders
  • DNA Repair
  • Drug Resistance
  • Ear Disorders
  • Economic development
  • Education and training
  • Electrophoresis
  • Eli Lilly
  • Employment Trends
  • Endocrine Disorders
  • Evolution
  • Extracellular Matrix
  • Eye Disorders
  • Fill and Finish
  • Financing
  • Flow Cytometry
  • Forensics
  • Fungal Diseases
  • Gastrointestinal Disorders
  • GEN 40
  • GEN Edge
  • Genentech
  • Genetic Disease Testing
  • Genetics
  • Glycan Analysis
  • Glycoproteins
  • GWAS
  • Hematologic Conditions
  • Histology
  • HPLC
  • Hypertension
  • Imaging
  • Immunoassay
  • Immunochemistry
  • Immunology
  • In-vitro Fertilization
  • Industry News
  • Inflammatory Diseases
  • Information Management
  • Insights
  • interleukin
  • Ion Channels
  • Kidney Diseases
  • Kinases
  • Literature Review
  • Liver Diseases
  • Lung Cancer
  • Lung Diseases
  • Magazine
  • Marijuana
    Latest
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Financing

    EY Eyes Comeback for Biopharma M&A

    Immuno-oncology

    Cancer I-O Pioneer, Executive Target Immune Disruption with $65M Startup

    Cell Therapy

    BMS, Immatics Launch Up-to-$4.2B Expanded Cancer Cell Therapy Collaboration

    Drug Discovery

    Nektar Eliminates 70% of Workforce, 500+ Jobs, in Restructuring

    Immuno-oncology

    StockWatch: Checkmate Shares Quadruple on Regeneron Buyout

    Immuno-oncology

    Regeneron to Acquire Checkmate for $250M, Expanding Cancer I/O Pipeline

    Cancer

    Cardinal CIN: Volastra, BMS Commence Up-to-$1.13B Cancer Collaboration

    Gastrointestinal Disorders

    Inflection Point: Abivax Challenges Pharma Giants in Ulcerative Colitis

    Bristol-Myers Squibb

    Bristol-Myers Squibb to Acquire MyoKardia for $13.1B, Expanding Cardiovascular Franchise

    Bristol-Myers Squibb

    Amgen Eyes Inflammatory Disease Expansion with Planned $13.4B Purchase of Celgene’s...

    Bristol-Myers Squibb

    Celgene Scraps $2.6B Deal, Licenses Jounce Antibody in Restructured Cancer Collaboration

    Bristol-Myers Squibb

    BMS Selling Celgene’s Otezla to Address FTC “Concerns” on $74B Deal

    Bristol-Myers Squibb

    Catalent Acquires BMS Manufacturing Plant in Italy, Expanding Biologics Operations

    Recently Featured

    Poor Lung Cancer Response to Immunotherapy Linked to Commensal Bacteria, Suppressed T-Cell Activation

    Poor Lung Cancer Response to Immunotherapy Linked to Commensal Bacteria, Suppressed T-Cell Activation

    How Well Do Mouse Models Mimic Human Disease?

    How Well Do Mouse Models Mimic Human Disease?

    How Signaling Molecules of the Immune System Protect against Disease

    How Signaling Molecules of the Immune System Protect against Disease

    Spatial Biology Current State of the Art and What’s Coming Next

    Spatial Biology Current State of the Art and What’s Coming Next

    Read the Digital Edition

    GEN February 2023 cover

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up